Microbial Sensitivity Tests
"Microbial Sensitivity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
Descriptor ID |
D008826
|
MeSH Number(s) |
E01.370.225.875.595 E05.200.875.595 E05.337.550.400
|
Concept/Terms |
Microbial Sensitivity Tests- Microbial Sensitivity Tests
- Microbial Sensitivity Test
- Sensitivity Test, Microbial
- Sensitivity Tests, Microbial
- Test, Microbial Sensitivity
- Tests, Microbial Sensitivity
- Drug Sensitivity Assay, Microbial
Minimum Inhibitory Concentration- Minimum Inhibitory Concentration
- Concentration, Minimum Inhibitory
- Concentrations, Minimum Inhibitory
- Inhibitory Concentration, Minimum
- Inhibitory Concentrations, Minimum
- Minimum Inhibitory Concentrations
Bacterial Sensitivity Tests- Bacterial Sensitivity Tests
- Tests, Bacterial Sensitivity
- Sensitivity Tests, Bacterial
- Test, Bacterial Sensitivity
- Bacterial Sensitivity Test
- Sensitivity Test, Bacterial
|
Below are MeSH descriptors whose meaning is more general than "Microbial Sensitivity Tests".
Below are MeSH descriptors whose meaning is more specific than "Microbial Sensitivity Tests".
This graph shows the total number of publications written about "Microbial Sensitivity Tests" by people in this website by year, and whether "Microbial Sensitivity Tests" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 10 | 11 |
1996 | 2 | 9 | 11 |
1997 | 2 | 12 | 14 |
1998 | 0 | 13 | 13 |
1999 | 0 | 25 | 25 |
2000 | 0 | 22 | 22 |
2001 | 3 | 20 | 23 |
2002 | 0 | 29 | 29 |
2003 | 3 | 36 | 39 |
2004 | 0 | 43 | 43 |
2005 | 3 | 40 | 43 |
2006 | 0 | 47 | 47 |
2007 | 0 | 50 | 50 |
2008 | 2 | 41 | 43 |
2009 | 1 | 59 | 60 |
2010 | 4 | 57 | 61 |
2011 | 2 | 55 | 57 |
2012 | 2 | 57 | 59 |
2013 | 3 | 61 | 64 |
2014 | 4 | 62 | 66 |
2015 | 6 | 78 | 84 |
2016 | 7 | 68 | 75 |
2017 | 4 | 70 | 74 |
2018 | 3 | 61 | 64 |
2019 | 7 | 74 | 81 |
2020 | 1 | 82 | 83 |
2021 | 1 | 98 | 99 |
2022 | 0 | 52 | 52 |
2023 | 1 | 53 | 54 |
2024 | 20 | 21 | 41 |
2025 | 0 | 2 | 2 |
Below are the most recent publications written about "Microbial Sensitivity Tests" by people in Profiles.
-
Essential oils modulate virulence phenotypes in a multidrug-resistant pyomelanogenic Pseudomonas aeruginosa clinical isolate. Sci Rep. 2025 Jan 30; 15(1):3738.
-
Carbapenem-resistant Enterobacterales infection and colonization in patients with severe burns: a retrospective cohort study in a single burn center. Antimicrob Resist Infect Control. 2025 Jan 29; 14(1):3.
-
In vitro resensitization of multidrug-resistant clinical isolates of Enterococcus faecium and E. faecalis through phage-antibiotic synergy. Antimicrob Agents Chemother. 2025 Feb 13; 69(2):e0074024.
-
Impact of rapid antibiotic susceptibility testing for Gram-negative bacteremia varies by pathogen type and resistance: a secondary analysis of the RAPIDS GN trial. Microbiol Spectr. 2025 Feb 04; 13(2):e0178924.
-
Rapid Antibiotic Susceptibility Determination by Fluorescence Lifetime Tracking of Bacterial Metabolism. ACS Infect Dis. 2024 Dec 13; 10(12):4057-4065.
-
Biologically active ionic chitosan Schiff base nanocomposites: Synthesis, characterization and antimicrobial activity against Helicobacter pylori. Int J Biol Macromol. 2024 Dec; 282(Pt 5):137321.
-
Dual β-lactams for the treatment of Mycobacterium abscessus: a review of the evidence and a call to act against an antibiotic nightmare. J Antimicrob Chemother. 2024 Nov 04; 79(11):2731-2741.
-
Antimicrobial susceptibility profiles among commensal Mannheimia haemolytica and Pasteurella multocida isolated from apparently healthy sheep processed in California: Results from a cross-sectional pilot study. Prev Vet Med. 2024 Dec; 233:106360.
-
Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trial. Lancet Microbe. 2024 Dec; 5(12):100928.
-
A Three-year Longitudinal Assessment of Pseudomonas aeruginosa Antibiotic Susceptibility in Children With Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy. Pediatr Infect Dis J. 2025 Mar 01; 44(3):e77-e80.